Some studies report that these or other IGF polymorphisms modestly affect circulating levels of IGF-I and IGFBP-3 [6], [8], [9], [10], [11], [12], but there is limited support for a direct effect on breast cancer risk. The gene discussed is IGF1; the disease is breast carcinoma.